Skip to main content
. 2011 Nov 10;6(11):e26640. doi: 10.1371/journal.pone.0026640

Table 1. Tumor incidence rate in transgenic mice after N-methyl-N-nitrosourea treatment.

Genotype Squamous cell carcinoma/papilloma (Stomach) Squamous cell papilloma (Skin) Malignant lymphoma (Hematopoietic system)
RasHOL 6.7%* 0% 60%
Ras+HOL 87.5% 37.5% 50%
RasHOL+ 0% 0% 55.6%
Ras+HOL+ 62.5% 37.5% 75%

*Tumor incidence rate. Carcinogenicity test of 15 mice from each of the following offspring type: CB6F1-albino (RasHOL), CB6F1-albino-rasH2 (Ras+HOL), C6F1-albino-HOL (RasHOL+), and CB6F1-albino-rasH2-HOL (Ras+HOL+) were performed by administering N-methyl-N-nitrosourea. The mice that were alive at the end of the experimental period were necropsied, and systemic visual observations were performed.